Target Name: HTN3
NCBI ID: G3347
Review Report on HTN3 Target / Biomarker Content of Review Report on HTN3 Target / Biomarker
HTN3
Other Name(s): Basic histidine-rich protein | His3 1/24 | His3-(26-30)-peptide | Histatin-3 5/13 | histatin 3 | Histatin-3 1/11 | His3-(34-44)-peptide | His3 5/11 | Histatin-3 12/24 | His3 20/31 | His3-(6-11)-peptide | His3 6/11 | histatin-5 | His3 29/32 | His3 7/12 | His3 14/25 | His3 26/32 | His3-(15-24)-peptide | Histatin-3 6/13 | His3-(5-13)-peptide | His3-(24-32)-peptide | His3-(1-12)-peptide | His3 1/25 | Histatin-3 12/25 | Histatin-3 1/13 | Histatin-3 7/12 | His3-(14-24)-peptide | His3 26/31 | His3-(26-31)-peptide | His3-(1-13)-peptide | Histatin 5 | His3 6/13 | His3-(20-31)-peptide | His3 32/44 | His3-(7-12)-peptide | His3-(12-24)-peptide | Histatin 3 | His3 5/13 | histatin-6 | His3 20/32 | His3 45/51 | His3 26/30 | His3-(31-44)-peptide | His3-(13-24)-peptide | PB | His3 24/32 | His3 5/12 | histatin-7 | His3 33/44 | His3 28/32 | His3-(33-44)-peptide | Histatin-3 15/24 | His3 1/11 | His3 7/11 | His3 34/43 | Histatin-3 6/11 | Histatin-3 5/11 | Histatin-6 | His3 12/25 | His3-(12-25)-peptide | His3-(7-13)-peptide | Histatin-12 | Histatin-3 14/24 | His3 1/12 | His3-(31-51)-peptide | His3-(20-30)-peptide | His3 31/44 | His3-(45-51)-peptide | His3-(29-32)-peptide | histatin-9 | His3-(7-11)-peptide | His3 32-43 | His3 24/30 | Histatin-8 | Histatin-3 29/32 | His3 33/43 | Histatin-3 12/32 | Histatin-3 14/25 | Histatin-9 | HIS3_HUMAN | HIS2 | His3 1/13 | Histatin-3 5/12 | His3 47/51 | His3 24/31 | His3 25/30 | histidine-rich protein 3 | Histatin-3 1/12 | His3-(32-43)-peptide | Histatin-3 7/11 | Histatin-4 | Histatin-3 | Histatin-3 13/25 | His3 15/24 | HTN5 | His3-(12-32)-peptide | histatin-8 | His3-(25-32)-peptide | His3 12/24 | His3-(5-12)-peptide | Histidine-rich protein 3 | Histatin-3 1/24 | Histatin-7 | His3-(13-25)-peptide | Histatin-3 1/25 | His3-(47-51)-peptide | Histatin-5 | His3-(26-32)-peptide | His3-(15-25)-peptide | His3-(33-43)-peptide | His3 13/25 | His3 13/24 | His3 34/44 | Histatin-10 | His3-(20-44)-peptide | Histatin-3 13/24 | Hst | His3 7/13 | His3 20/44 | His3-(1-24)-peptide | His3 25/32 | His3 12/32 | His3-(24-30)-peptide | His3-(25-30)-peptide | His3-(1-11)-peptide | His3-(1-25)-peptide | His3 14/24 | His3 20/43 | basic histidine-rich protein | His3 48/51 | His3 15/25 | His3-(32-44)-peptide | His3-(48-51)-peptide | Histatin-3 15/25 | Histatin-3 28/32 | Histatin-11 | His3-(34-43)-peptide | His3-(20-32)-peptide | His3-(5-11)-peptide | His3-(14-25)-peptide | His3 31/51 | HTN2 | histatin-4 | His3-(28-32)-peptide | His3 31/43 | His3-(6-13)-peptide | His3-(24-31)-peptide | Histatin-3 7/13 | His3-(20-43)-peptide | Histatin-3 26/32 | His3-(31-43)-peptide | His3 20/30

HTN3: A Basic Histidine-Rich Protein That May Be a Drug Target or Biomarker

Histidine-rich proteins (HRPs) are a class of biomarkers that have been identified for their ability to interact with histidine, a chemical found in many proteins, as well as their ability to modulate various cellular processes. One such protein that has gained significant interest in recent years is HTN3, a protein that is expressed in a wide range of tissues and cells and is characterized by its ability to interact with histidine.

In this article, we will explore HTN3 and its potential as a drug target or biomarker. We will discuss the structure and function of HTN3, as well as its potential clinical applications and the research that has been done to study its potential.

Structure and Function of HTN3

HTN3 is a protein that is composed of 118 amino acid residues and has a calculated molecular mass of 13.9 kDa. It is characterized by its ability to interact with histidine and its ability to modulate various cellular processes.

One of the key features of HTN3 is its ability to interact with histidine. Histidine is a chemical that is found in many proteins and is involved in various cellular processes, including DNA replication, protein synthesis, and cell signaling. HTN3 has been shown to be able to interact with histidine and modulate the activity of various proteins.

In addition to its ability to interact with histidine, HTN3 is also characterized by its ability to modulate various cellular processes. For example, HTN3 has been shown to be involved in the regulation of cell adhesion, cell signaling, and cell cycle progression. It is also involved in the regulation of inflammation and immune response.

Potential Clinical Applications

HTN3 has the potential to be a drug target or biomarker in a variety of diseases. For example, HTN3 has been shown to be involved in the regulation of cancer cell growth and has been shown to have anti-tumor effects. Additionally, HTN3 has been shown to be involved in the regulation of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential as a drug target or biomarker, HTN3 also has the potential to be used as a diagnostic tool. For example, HTN3 has been shown to be expressed in a wide range of tissues and cells and can be used as a protein biomarker for various diseases.

Research on HTN3

Several studies have been conducted to study HTN3 and its potential as a drug target or biomarker. For example, researchers have shown that HTN3 is able to interact with histidine and that this interaction modulates the activity of various proteins. Additionally, researchers have shown that HTN3 is involved in the regulation of cell adhesion, cell signaling, and cell cycle progression.

There is also evidence to suggest that HTN3 may have anti-tumor effects and may be a potential drug target for cancer. Researchers have shown that HTN3 has been shown to inhibit the growth of various types of cancer cells and has been shown to have anti-tumor effects in animal models of cancer.

In addition to its potential as a drug target or biomarker, HTN3 also has the potential to be used as a diagnostic tool. Researchers have shown that HTN3 is expressed in a wide range of tissues and cells and can be used as a protein biomarker for various diseases.

Conclusion

In conclusion, HTN3 is a protein that is characterized by its ability to interact with histidine and its ability to modulate various cellular processes. HTN3 has the potential to be a drug target or biomarker in a variety of diseases, including cancer and autoimmune diseases. Further research is needed to fully understand the role of HTN3 in these diseases and to develop its potential as a diagnostic tool.

Protein Name: Histatin 3

Functions: Histatins are salivary proteins that are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). In addition, histatins exhibit antibacterial and antifungal activities. His3-(20-43)-peptide (histatin-5) is especially effective against C.albicans and C.neoformans, and inhibits Lys-gingipain and Arg-gingipain (rgpB) from P.gingivalis. In addition, His3-(20-43)-peptide is a potent inhibitor of metalloproteinases MMP2 and MMP9

The "HTN3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HTN3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

HTR1A | HTR1D | HTR1E | HTR1F | HTR2A | HTR2A-AS1 | HTR2B | HTR2C | HTR3A | HTR3B | HTR3C | HTR3D | HTR3E | HTR3E-AS1 | HTR4 | HTR5A | HTR5A-AS1 | HTR5BP | HTR6 | HTR7 | HTR7P1 | HTRA1 | HTRA2 | HTRA3 | HTRA4 | HTT | HTT-AS | HULC | Human chorionic gonadotropin | HUNK | HUS1 | HUS1B | HUWE1 | HVCN1 | HYAL1 | HYAL2 | HYAL3 | HYAL4 | HYAL6P | Hyaluronidase | HYCC1 | HYCC2 | HYDIN | HYI | HYKK | HYLS1 | HYMAI | HYOU1 | HYPK | Hypoxia inducible factor (HIF) | Hypoxia-Inducible Factor Prolyl Hydroxylase | I-kappa-B-kinase (IKK) complex | IAH1 | IAPP | IARS1 | IARS2 | IATPR | IBA57 | IBA57-DT | IBSP | IBTK | ICA1 | ICA1L | ICAM1 | ICAM2 | ICAM3 | ICAM4 | ICAM5 | ICE1 | ICE2 | ICMT | ICMT-DT | ICOS | ICOSLG | ID1 | ID2 | ID2-AS1 | ID2B | ID3 | ID4 | IDE | IDH1 | IDH1-AS1 | IDH2 | IDH2-DT | IDH3A | IDH3B | IDH3G | IDI1 | IDI2 | IDI2-AS1 | IDNK | IDO1 | IDO2 | IDS | IDSP1 | IDUA | IER2 | IER3 | IER3-AS1